206 related articles for article (PubMed ID: 24103424)
1. Characteristics of cases with unknown stage prostate cancer in a population-based cancer registry.
Luo Q; Yu XQ; Cooke-Yarborough C; Smith DP; O'Connell DL
Cancer Epidemiol; 2013 Dec; 37(6):813-9. PubMed ID: 24103424
[TBL] [Abstract][Full Text] [Related]
2. Cancer-related hospitalisations and 'unknown' stage prostate cancer: a population-based record linkage study.
Luo Q; Yu XQ; Smith DP; Goldsbury DE; Cooke-Yarborough C; Patel MI; O'Connell DL
BMJ Open; 2017 Jan; 7(1):e014259. PubMed ID: 28077413
[TBL] [Abstract][Full Text] [Related]
3. Socio-demographic disadvantage and distant summary stage of cancer at diagnosis--A population-based study in New South Wales.
Tervonen HE; Walton R; Roder D; You H; Morrell S; Baker D; Aranda S
Cancer Epidemiol; 2016 Feb; 40():87-94. PubMed ID: 26703888
[TBL] [Abstract][Full Text] [Related]
4. Patterns of surgical care for prostate cancer in NSW, 1993-2002: rural/urban and socio-economic variation.
Hayen A; Smith DP; Patel MI; O'Connell DL
Aust N Z J Public Health; 2008 Oct; 32(5):417-20. PubMed ID: 18959543
[TBL] [Abstract][Full Text] [Related]
5. Predictors and survival in hepatitis B-related hepatocellular carcinoma in New South Wales, Australia.
Nguyen VT; Amin J; Law MG; Dore GJ
J Gastroenterol Hepatol; 2009 Mar; 24(3):436-42. PubMed ID: 19175834
[TBL] [Abstract][Full Text] [Related]
6. What factors affect the odds of NSW cancer patients presenting with localised as opposed to more advanced cancer?
Tracey EA; Roder DM; Currow DC
Cancer Causes Control; 2012 Feb; 23(2):255-62. PubMed ID: 22120005
[TBL] [Abstract][Full Text] [Related]
7. Bladder cancer survivals in New South Wales, Australia: why do women have poorer survival than men?
Tracey E; Roder D; Luke C; Bishop J
BJU Int; 2009 Aug; 104(4):498-504. PubMed ID: 19338538
[TBL] [Abstract][Full Text] [Related]
8. Unstaged cancer in a population-based registry: prevalence, predictors and patient prognosis.
Gurney J; Sarfati D; Stanley J; Dennett E; Johnson C; Koea J; Simpson A; Studd R
Cancer Epidemiol; 2013 Aug; 37(4):498-504. PubMed ID: 23548729
[TBL] [Abstract][Full Text] [Related]
9. Differences in survival from prostate cancer in Denmark, Iceland and Sweden.
Brasso K; Ingimarsdóttir IJ; Rusch E; Engholm G; Adolfsson J; Tryggvadóttir L; Jónsson E; Bill-Axelson A; Holmberg E; Storm HH
Eur J Cancer; 2013 May; 49(8):1984-92. PubMed ID: 23453749
[TBL] [Abstract][Full Text] [Related]
10. A population-based study of progression to metastatic prostate cancer in Australia.
Luo Q; Yu XQ; Smith DP; O'Connell DL
Cancer Epidemiol; 2015 Aug; 39(4):617-22. PubMed ID: 25983117
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer incidence and newly diagnosed patient profile in Spain in 2010.
Cózar JM; Miñana B; Gómez-Veiga F; Rodríguez-Antolín A; Villavicencio H; ; Cantalapiedra A; Pedrosa E
BJU Int; 2012 Dec; 110(11 Pt B):E701-6. PubMed ID: 22989066
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer incidence, stage at diagnosis, treatment and survival in ethnic groups in South-East England.
Jack RH; Davies EA; Møller H
BJU Int; 2010 May; 105(9):1226-30. PubMed ID: 19878505
[TBL] [Abstract][Full Text] [Related]
13. Validity of registry data: agreement between cancer records in an end-stage kidney disease registry (voluntary reporting) and a cancer register (statutory reporting).
Webster AC; Supramaniam R; O'Connell DL; Chapman JR; Craig JC
Nephrology (Carlton); 2010 Jun; 15(4):491-501. PubMed ID: 20609104
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer prevalence in New South Wales Australia: a population-based study.
Yu XQ; Luo Q; Smith DP; Clements MS; O'Connell DL
Cancer Epidemiol; 2015 Feb; 39(1):29-36. PubMed ID: 25530551
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005.
Adolfsson J; Garmo H; Varenhorst E; Ahlgren G; Ahlstrand C; Andrén O; Bill-Axelson A; Bratt O; Damber JE; Hellström K; Hellström M; Holmberg E; Holmberg L; Hugosson J; Johansson JE; Petterson B; Törnblom M; Widmark A; Stattin P
Scand J Urol Nephrol; 2007; 41(6):456-77. PubMed ID: 17934985
[TBL] [Abstract][Full Text] [Related]
16. Adenocarcinoma of the prostate in Iceland: a population-based study of stage, Gleason grade, treatment and long-term survival in males diagnosed between 1983 and 1987.
Jonsson E; Sigbjarnarson HP; Tomasson J; Benediktsdottir KR; Tryggvadottir L; Hrafnkelsson J; Olafsdottir EJ; Tulinius H; Jonasson JG
Scand J Urol Nephrol; 2006; 40(4):265-71. PubMed ID: 16916765
[TBL] [Abstract][Full Text] [Related]
17. Explaining the race difference in prostate cancer stage at diagnosis.
Jones BA; Liu WL; Araujo AB; Kasl SV; Silvera SN; Soler-Vilá H; Curnen MG; Dubrow R
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2825-34. PubMed ID: 18829446
[TBL] [Abstract][Full Text] [Related]
18. The association of ultraviolet radiation-B (305 nm), season of diagnosis, and latitude on the survival outcome of prostate cancer in the high UV environment of Australia.
Nair-Shalliker V; Smith DP; Egger S; Clements MS; Rahman MB; Armstrong BK
Cancer Causes Control; 2013 Nov; 24(11):2005-11. PubMed ID: 23974842
[TBL] [Abstract][Full Text] [Related]
19. Survival and degree of spread for female breast cancers in New South Wales from 1980 to 2003: implications for cancer control.
Tracey E; Roder D; Zorbas H; Villanueva E; Jelfs P; Bishop J
Cancer Causes Control; 2008 Dec; 19(10):1121-30. PubMed ID: 18521714
[TBL] [Abstract][Full Text] [Related]
20. Geographic patterns of prostate cancer mortality and variations in access to medical care in the United States.
Jemal A; Ward E; Wu X; Martin HJ; McLaughlin CC; Thun MJ
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):590-5. PubMed ID: 15767335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
